Table 3.
Comparison of Serum Lipid, OxLDL, HsCRP, cEMPs, cEPCs, CK, and ALT Between 2 Study Groups at the End of the Study ( )
TC, mmol/L | LDL, mmol/L | oxLDL, mmol/L | hsCRP, mg/L | cEMPs, n/µL | cEPCs, % | CK, mmol/L | ALT, mmol/L | |
---|---|---|---|---|---|---|---|---|
10‐mg group (n = 47) | 4.60 ± 0.63 | 2.55 ± 0.57 | 2.25 ± 1.13 | 6.36 ± 3.57 | 1847.98 ± 180.26 | 0.055 ± 0.019 | 103.58 ± 36.04 | 30.62 ± 5.90 |
40‐mg group (n = 48) | 4.16 ± 0.62 | 2.19 ± 0.69 | 1.50 ± .66 | 3.43 ± 1.99 | 1683.75 ± 118.58 | 0.065 ± .018 | 106.65 ± 7.03 | 32.37 ± 6.62 |
Significance | 0.001 | 0.008 | 0.000 | 0.000 | 0.000 | 0.014 | 0.683 | 0.176 |
Abbreviations: ALT, alanine transaminase; cEMPs, circulating endothelial‐derived microparticles; cEPCs, circulating endothelial progenitor cells; CK, creatine kinase; hsCRP, high‐sensitivity C‐reactive protein; LDL, low‐density lipoprotein; oxLDL, oxidized low‐density protein; TC, total cholesterol. P < 0.05 indicates statistical significance.